Cellular and molecular mechanisms underlying learning and memory impairments produced by cannabinoids

Learning and Memory

Volumn 7, Issue 3, 2000, Pages 132-139

  Sullivan, Jane M ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; CALCIUM CHANNEL; CANNABINOID; CANNABINOID RECEPTOR; CANNABIS; GLUTAMIC ACID; GUANINE NUCLEOTIDE BINDING PROTEIN;

4 AMINOBUTYRIC ACID RELEASE; ACETYLCHOLINE RELEASE; AMNESIA; BRAIN FUNCTION; CENTRAL NERVOUS SYSTEM DEPRESSION; CYTOLOGY; HIPPOCAMPUS; HUMAN; LEARNING DISORDER; LONG TERM POTENTIATION; MOLECULAR BIOLOGY; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DENSITY; REVIEW; SHORT TERM MEMORY;

ANIMALS; CANNABINOIDS; HIPPOCAMPUS; LEARNING DISORDERS; LONG-TERM POTENTIATION; MEMORY DISORDERS; NEUROTRANSMITTER AGENTS; RECEPTORS, CANNABINOID; RECEPTORS, DRUG;

EID: 0034118564     PISSN: 10720502     EISSN: None     Source Type: Journal    
DOI: 10.1101/lm.7.3.132     Document Type: Review

References (64)

1. Aigner, T.G. 1988. Delta-9-tetrahydrocannabinol impairs visual recognition memory but not discrimination learning in rhesus monkeys. Psychopharmacology 95: 507-511.
2. Ameri, A., A. Wilhelm, and T. Simmet. 1999. Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices. Br. J. Pharmacol. 126: 1831-1839.
3. Bear, M.F. and W.C. Abraham. 1996. Long-term depression in hippocampus. Ann. Rev. Neurosci. 19: 437-462.
4. Bidaut-Russell, M., W.A. Devane, and A.C. Howlett. 1990. Cannabinoid receptors and modulation of cyclic AMP accumulation in the rat brain. J. Neurochem. 55: 21-26.
5. Bohme, G.A., M. Laville, C. Ledent, M. Parmentier, and A. Imperato. 2000. Enhanced long-term potentiation in mice lacking cannabinoid CB1 receptors. Neuroscience 95: 5-7.
6. Brodkin, J. and J.M. Moerschbaecher. 1997. SR141716A antagonizes the disruptive effects of cannabinoid ligands on learning in rats. J. Pharmacol. Exp. Ther. 282: 1526-1532.
7. Campbell, K.A., T.C. Foster, R.E. Hampson, and S.A. Deadwyler. 1986a. delta 9-Tetrahydrocannabinol differentially affects sensory-evoked potentials in the rat dentate gyrus. J. Pharmacol. Exp. Ther. 239: 936-940.
8. Campbell, K.A., T.C. Foster, R.E. Hampson, and S.A. Deadwyler. 1986b. Effects of delta 9-tetrahydrocannabinol on sensory-evoked discharges of granule cells in the dentate gyrus of behaving rats. J. Pharmacol. Exp. Ther. 239: 941-945.
9. Chait, L.D. and J. Pierri. 1992. The cannabinoid receptor. In Marinjuana/cannabinoids: Neurobiology and neurophysiology (eds. L. Murphy and A. Bartke), pp. 387-423. CRC Press, Boca Raton, FL.
10. Childers, S.R. and C.S. Breivogel. 1998. Cannabis and endogenous cannabinoid systems. Drug Alcohol Depend. 51: 173-187.
11. Childers, S.R., T. Sexton, and M.B. Roy. 1994. Effects of anandamide on cannabinoid receptors in rat brain membranes. Biochem. Pharmacol. 47: 711-715.
12. Collins, D.R., R.G. Pertwee, and S.N. Davies. 1994. The action of synthetic cannabinoids on the induction of long-term potentiation in the rat hippocampal slice. Eur. J. Pharmacol. 259: R7-8.
13. Collins, D.R., R.G. Pertwee, and S.N. Davies. 1995. Prevention by the cannabinoid antagonist, SR141716A, of cannabinoid-mediated blockade of long-term potentiation in the rat hippocampal slice. Brit. J. Pharmacol. 115: 869-870.
14. Crawley, J.N., R.L. Corwin, J.K. Robinson, C.C. Felder, W.A. Devane, and J. Axelrod. 1993-Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents. Pharmacol. Biochem. Behav. 46: 967-972.
15. Deadwyler, S.A., R.E. Hampson, J. Mu, A. Whyte, and S. Childers. 1995. Cannabinoids modulate voltage sensitive potassium A-current in hippocampal neurons via a cAMP-dependent process. J. Pharmacol. Exp. Ther. 273: 734-743.
16. Devane, W.A., L. Hanus, A. Breuer, R.G. Pertwee, L.A. Stevenson. G. Griffin, D. Gibson, A. Mandelbaum, A. Etinger, and R. Mechoulam. 1992. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946-1949.
17. Dolphin, A.C. 1998. Mechanisms of modulation of voltage-dependent calcium channels by G proteins. J. Physiol. Ser. (Lond) 506: 3-11
18. Felder, C.C., A. Nielsen, E.M. Briley, M. Palkovits, J. Priller, J. Axelrod, D.N. Nguyen, J.M. Richardson, K.M. Riggin, G.A. Koppel et al. 1996. Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. FEBS Lett. 393: 231-235.
19. Gessa, G.L., M.S. Mascia, M.A. Casu, and G. Carta. 1997. Inhibition of hippocampal acetylcholine release by cannabinoids: Reversal by SR 141716A. Eur. J. Pharmacol. 327:R1-2.
20. Gifford, A.N. and C.R. Ashby, Jr. 1996. Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A. J. Pharmacol. Exp. Ther. 277: 1431-1436.
21. Hampson, R.E. and S.A. Deadwyler. 1998. Role of cannabinoid receptors in memory storage. Neurobiol. Dis. 5: 474-482.
22. Henry, D.J. and C. Chavkin. 1995. Activation of inwardly rectifying potassium channels (GIRK1) by co- expressed rat brain cannabinoid receptors in Xenopus oocytes. Neurosci. Lett. 186: 91-94.
23. Herkenham, M., A.B. Lynn, M.D. Little, M.R. Johnson, L.S. Melvin, and B.R. De Costa. 1990. Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. 87: 1932-1936.
24. Herkenham, M., A.B. Lynn, M.R. Johnson, L.S. Melvin, B.R. de Costa, and K.C. Rice. 1991. Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro auturadiographic study. J. Neurosci. 11: 563-583.
25. Heyser, C.J., R.E. Hampson, and S.A. Deadwyler. 1993. Effects of Delta-9-Tetrahydrocannabinol on delayed match to sample performance in rats: Alterations in short-term memory associated with changes in task specific firing of hippocampal cells. J. Pharmacol. Exp. Ther. 264: 294-307.
26. Hollister, L.E. 1984. Health aspects of cannabis use. In The cannabinoids: Chemical, pharmacological and therapeutic aspects (eds. S. Agurell, W.L. Dewey, and R.E. Willette), pp. 3-20. Academic Press, New York, NY.
27. Howlett, A.C. 1995. Pharmacology of cannabinoid receptors. Ann. Rev. Pharmacol. Toxicol. 35: 607-634.
28. Howlett, A.C., D.M. Evans, and D.E. Houston. 1992. The cannabinoid receptor. In Marinjuana/cannabinoids: Neurobiology and neurophysiology (eds. L. Murphy and A. Bartke), pp. 35-72. CRC Press, Boca Raton, FL.
29. Katona, I., B. Sperlagh, A. Sik, A. Kafalvi, E.S. Vizi, K. Mackie, and T.F. Freund. 1999 Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J. Neurosci. 19: 4544-4558.
30. Kirby, M.T., R.E. Hampson, and S.A. Deadwyler. 1995. Cannabinoids selectively decrease paired-pulse facilitation of perforant path synaptic potentials in the dentate gyrus in vitro. Brain Res. 688: 114-120.
31. Landsman, R.S., T.H. Burkey, P. Consroe, W.R. Roeske, and H.I. Yamamura. 1997. SR141716A is an inverse agonist at the human cannabinoid CB1 receptor. Eur. J. Pharmacol. 334: R1-2.
32. Lichtman, A.H. and B.R. Martin. 1996. Delta 9-tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism. Psychopharmacology Ser. (Berl) 126: 125-131.
33. Lichtman, A.H., K.R. Dimen, and B.R. Martin. 1995. Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats. Psychopharmacology Ser. (Berl) 119: 282-290.
34. Mackie, K. and B. Hille. 1992. Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc. Natl. Acad. Sci. 89: 3825-3829.
35. Mackie, K., Y. Lai, R. Westenbroek, and R. Mitchell. 1995. Cannabinoids activate an inwardly rectifying Potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J. Neurosci. 15: 6552-6561.
36. Malenka, R.C. and R.A. Nicoll. 1993. NMDA-receptor-dependent synaptic plasticity: Multiple forms and mechanisms. Trends Neurosci. 16: 521-527.
37. Mallet, P.E. and R.J. Beninger. 1996. The endogenous cannabinoid receptor agonist anandamide impairs memory in rats. Behav. Pharmacol. 7: 276-284.
38. Matsuda, L.A., S.J. Lolait, M.J. Brownstein, A.C. Young, and T.I. Bonner. 1990. Structure of a cannabincid receptor and functional expression of the cloned cDNA. Nature 346: 561-564.
39. Miller, L.L. 1984. Marijuana: Acute effects on human memory. In The cannabinoids: Chemical, pharmacological and therapeutic aspects (eds. S. Agurell, W.L. Dewey, and R.E. Wilette), pp. 21-46. Academic Press, New York, NY.
40. Miller, L.L. and R.J. Branconnier. 1983 Cannabis: Effects on memory and the cholinergic limbic system. Psychol. Bull. 93: 441-456.
41. Misner, D.L. and J.M. Sullivan. 1999. Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CAl neurons. J. Neurosci. 19: 6795-6805.
42. Munro, S., K.L. Thomas, and M. Abu-Shaar. 1993. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365: 61-65.
43. 2+ signals in cerebellar granule neurons in culture. J. Neurosci. 19: 8765-8777.
44. Nicoll, R.A. and R.C. Malenka. 1995. Contrasting properties of two forms of long-term potentiation in the hippocampus. Nature 377: 115-118.
45. Nowicky, A.V., T.J. Teyler, and R.M. Vardaris. 1987. The modulation of long-term potentiation by delta-9-tetrahydrocannabinol in the rat hippocampus, in vitro. Brain Res. Bull. 19: 663-672.
46. Pachcco, M., S.R. Childers, R. Arnold, F. Casiano, and S.J. Ward. 1991. Aminoalkylindoles: Actions on specific G-protein-linked receptors. J. Pharmacol. Exp. Ther. 257: 170-183.
47. Paton, G.S., R.G. Pertwee, and S.N. Davies. 1998. Correlation between cannabinoid mediated effects on paired pulse depression and induction of long term potentiation in the rat hippocampal slice. Neuropharmacol. 37: 1123-1130.
48. Pettit, D.A., M.P. Harrison, J.M. Olson, R.F. Spencer, and G.A. Cabral. 1998. Immunohistochemical localization of the neural cannabinoid receptor in rat brain. J. Neurosci. Res. 51: 391-402.
49. Scanziani, M., M. Capogna, B.H. Gähwiler, and S.M. Thompson. 1992. Presynaptic inhibition of miniature excitatory synaptic currents by baclofen and andenosine in the hippocampus. Neuron 9: 919-927.
50. Shen, M. and S.A. Thayer. 1999. Delta9-tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture. Mol. Pharmacol. 55: 8-13.
51. Shen, M., T.M. Piser, V.S. Seybold, and S.A. Thayer. 1996. Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J. Neurosci. 16: 4322-4334.
52. Shen, M. and S.A. Thayer. 1998. The cannabinoid agonist Win55,212-2 inhibits calcium channels by receptor-mediated and direct pathways in cultured rat hippocampal neurons. Brain Res. 783: 77-84.
53. Stella, N., P. Schweitzer, and D. Piomelli. 1997. A second endogenous cannabinoid that modulates long-term potentiation. Nature 388: 773-778.
54. Stevens, C.F. 1998. A million dollar question: Does LTP = memory? Neuron 20: 1-2.
55. Sullivan, J.M. 1999. Mechanisms of cannabinoid-receptor-mediated inhibition of synaptic transmission in cultured hippocampal pyramidal neurons. J. Neurophysiol, 82: 1286-1294.
56. Takahashi, T. and A. Momiyama. 1993. Different types of calcium channels mediate central synaptic transmission. Nature 366: 156-158.
57. Terranova, J.P., J.C. Michaud, G. Le Fur, and P. Soubrie. 1995. Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: Reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors. Naunyn-Schmiedebergs Arch. Pharmakol. 352: 576-579.
58. Terranova, J.P., J.J. Storme, N. Lafon, A. Perio, M. Rinaldi-Carmona, G. Le Fur, and P. Soubrie. 1996. Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716. Psychopharmacology Ser. (Berl) 126: 165-172.
59. Tsou, K., S. Brown, M.C. Sanudo-Pena, K. Mackie, and J.M. Walker. 1998. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83: 393-411.
60. Tsou, K., K. Mackie, M.C. Sanudo-Pena, and J.M. Walker. 1999. Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation. Neuroscience 93: 969-975.
61. Twitchell, W., S. Brown, and K. Mackie. 1997. Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. J. Neurophysiol. 78: 43-50.
62. Vardaris, R.M. and D.J. Weisz. 1977. Delta9-tetrahydrocannabinol and the hippocampus: Effects on CA1 field potentials in rats. Brain Res. Bull. 2: 181-187.
63. Weisz, D.J., D.L. Gunnell, T.J. Teyler, and R.M. Vardaris. 1982. Changes in hippocampal CA1 population spikes following administration of delta-9-THC. Brain Res. Bull. 8: 155-162.
64. 2+ channels in supporting hippocampal synaptic transmission. Science 264: 107-111.